Evidence map›Paper›PMID 38969603›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2024

Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function.

Alice C Eastman, Gedge Rosson, Noori Kim, Sewon Kang, Karen Raraigh, Loyal A Goff, Christian Merlo, Noah Lechtzin, Garry R Cutting, Neeraj Sharma

Abstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alice C EastmanJohns Hopkins School of Medicine, Department of Human Genetics, Miller Research Building, 733N Broadway, Baltimore, MD 21205, USA.
Gedge RossonJohns Hopkins Medicine, Department of Plastic and Reconstructive Surgery, 601N Caroline St, Baltimore, MD 21287, USA.
Noori KimJohns Hopkins School of Medicine, Department Medicine, Division of Dermatology, 601N Caroline St, Baltimore, MD 21287, USA.
Sewon KangJohns Hopkins School of Medicine, Department Medicine, Division of Dermatology, 601N Caroline St, Baltimore, MD 21287, USA.
Karen RaraighJohns Hopkins School of Medicine, Department of Human Genetics, Miller Research Building, 733N Broadway, Baltimore, MD 21205, USA.
Loyal A GoffJohns Hopkins School of Medicine, Department of Human Genetics, Miller Research Building, 733N Broadway, Baltimore, MD 21205, USA.
Christian MerloJohns Hopkins University School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, 1800 Orleans St, Baltimore, MD 21287, USA.
Noah LechtzinJohns Hopkins University School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, 1800 Orleans St, Baltimore, MD 21287, USA.
Garry R CuttingJohns Hopkins School of Medicine, Department of Human Genetics, Miller Research Building, 733N Broadway, Baltimore, MD 21205, USA.
Neeraj SharmaJohns Hopkins School of Medicine, Department of Human Genetics, Miller Research Building, 733N Broadway, Baltimore, MD 21205, USA. Electronic address: nsharma5@jhmi.edu.

Funding

MOLECULAR GENETICS OF CYSTIC FIBROSISR01DK044003 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Garry R Cutting · 1991 to 2026
$6.7M
Molecular Genetics of Cystic FibrosisR37DK044003 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CUTTING, GARRY R · 2003 to 2012
$3.9M
Predoctoral Training Program in Human GeneticsT32GM148383 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Kimberly F Doheny, ANDREW S MCCALLION · 2023 to 2026
$2.4M
NIDDK NIH HHS R01 DK044003NIDDK NIH HHS R37 DK044003NIGMS NIH HHS T32 GM148383
6 · The paper itself

Abstract

backgroundSweat chloride concentration is used both for CF diagnosis and for tracking CFTR modulator efficacy over time, but the relationship between sweat chloride and lung health is heterogeneous and informed by CFTR genotype. Here, we endeavored to characterize ion transport in eccrine sweat glands (ESGs).

methodsFirst, ESGs were microdissected from a non-CF skin donor to analyze individual glands. We established primary cultures of ESG cells via conditional reprogramming for functional testing of ion transport by short circuit current measurement and examined cell composition by single-cell RNA-sequencing (scRNA-seq) comparing with whole dissociated ESGs. Secondly, we cultured nasal epithelial (NE) cells and ESGs from two people with CF (pwCF) to assess modulator efficacy. Finally, NEs and ESGs were grown from one person with the CFTR genotype F312del/F508del to explore genotype-phenotype heterogeneity.

resultsESG primary cells from individuals without CF demonstrated robust ENaC and CFTR function. scRNA-seq demonstrated both secretory and ductal ESG markers in cultured ESG cells. In both NEs and ESGs from pwCF homozygous for F508del, minimal baseline CFTR function was observed, and treatment with CFTR modulators significantly enhanced function. Notably, NEs from an individual bearing F312del/F508del exhibited significant baseline CFTR function, whereas ESGs from the same person displayed minimal CFTR function, consistent with observed phenotype.

conclusionsThis study has established a novel primary culture technique for ESGs that allows for functional ion transport measurement to assess modulator efficacy and evaluate genotype-phenoytpe heterogeneity. To our knowledge, this is the first reported application of conditional reprogramming and scRNA-seq of microdissected ESGs.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEccrine GlandsCells, CulturedHumansIon TransportCystic Fibrosis Transmembrane Conductance RegulatorCFTR functionConditional reprogrammingEccrine sweat glandsGenotype-phenotypeModulator heterogeneityscRNA-seq

Identifiers

PMID38969603
PMCPMC11624101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.